NVCT — Nuvectis Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $116.19m
- $96.73m
Annual cashflow statement for Nuvectis Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 0.01 | -12.9 | -19.1 | -22.3 |
| Non-Cash Items | — | 1.89 | 1.71 | 4.71 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.01 | 1.49 | 3.82 | 1.6 |
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | 0 | -9.5 | -13.6 | -16 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | — |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | 0 | 0 | — |
| Financing Cash Flow Items | 0 | — | -4.07 | -1.39 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 0 | 15.2 | 27.8 | 15.1 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0 | 5.74 | 14.3 | -0.867 |